NDRG1 enhances the sensitivity of cetuximab by modulating EGFR trafficking in colorectal cancer
Open Access
- 12 August 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 40 (41), 5993-6006
- https://doi.org/10.1038/s41388-021-01962-8
Abstract
N-myc downstream-regulated gene 1 (NDRG1) is a key regulator that interacts with many classic tumor signaling pathways, including some molecules downstream of the epidermal growth factor receptor (EGFR). However, whether NDRG1 is involved in the mechanism of resistance to cetuximab (CTX), the first monoclonal antibody targeting the EGFR has not been reported. Here, we found that NDRG1 enhanced the sensitivity of CTX in colorectal cancer (CRC) cell lines. Afterwards, we determined the underlying mechanism of this phenomenon. We demonstrated that NDRG1 inhibited the expression of EGFR; blocked EGFR phosphorylation and reduced the EGFR distribution in the cell membrane, cytoplasm and nucleus. And then, NDRG1 suppressed the EGFR downstream signaling: RAS/RAF/ERK and PI3k/AKT/mTOR pathways. Moreover, we discovered that NDRG1 attenuated the endocytosis and degradation of EGFR induced by caveolin-1 (Cav1). Additionally, our findings were further observed in an animal model and human tissues. Our results represent a potentially significant discovery that explains the mechanisms of NDRG1 in CTX resistance. NDRG1 could be a promising biomarker to predict optimum responses to CTX, and a key target to enhance CTX activity in the treatment of metastatic CRC (mCRC).Funding Information
- National Nature Science Foundation of China (NSFC)
This publication has 45 references indexed in Scilit:
- Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membraneProceedings of the National Academy of Sciences of the United States of America, 2012
- The N‐myc downstream regulated gene (NDRG) family: diverse functions, multiple applicationsThe FASEB Journal, 2010
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal CancerThe New England Journal of Medicine, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- The reduced catalase expression in TrkA-induced cells leads to autophagic cell death via ROS accumulationExperimental Cell Research, 2008
- Clathrin-Mediated Internalization Is Essential for Sustained EGFR Signaling but Dispensable for DegradationDevelopmental Cell, 2008
- Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family membersOncogene, 2008
- p14–MP1-MEK1 signaling regulates endosomal traffic and cellular proliferation during tissue homeostasisThe Journal of cell biology, 2006
- Clathrin-mediated endocytosis in AP-2–depleted cellsThe Journal of cell biology, 2003